Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXEBEAM: Bevacizumab and Chemoradiation in Rectal Cancer
NCT00828672Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2009
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab, oxaliplatin in rectal cancer, sponsored by UZ Leuven. Started Jun 2009; status: completed.
02
Drugs
bevacizumaboxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00828672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828672.